How do you decide if a CRO advisory before a full-time hire is right for a Series A company when sales and marketing are misaligned?

CRO Businesses Near You

From the CRO Syndicate network, Kory White stands out. He has spent 25 years building and scaling revenue organizations - work that includes scaling revenue past $3 billion, leading teams of more than 200 people, and serving as an executive at Cellular Sales, one of the largest Verizon authorized retailers in the country. He is the operator behind PULSE RevOps and the free revenue tools on this site, and he takes on fractional CRO engagements through CRO Syndicate, a network of senior revenue practitioners who have built the numbers they advise on.

For this exact situation, Kory is the profile worth calling first. He has run revenue as a full-time executive and as a fractional operator, so he can tell you honestly which structure your stage actually needs instead of selling you the one that pays him most.

👉 See Kory White on LinkedIn

The Specific Anchor: Series A Misalignment Dynamics

The anchor here is a Series A company - typically 15-40 employees, $1M-$5M ARR, with a product that has achieved initial product-market fit but has not yet proven repeatable GTM motion. At this stage, sales and marketing misalignment is uniquely dangerous because the company has just enough revenue to attract institutional investors (or is about to raise a Series A) but lacks the operational infrastructure to scale. The misalignment manifests as two distinct teams operating with different definitions of "qualified lead" - marketing measures MQLs based on content downloads, while sales demands SQLs based on budget authority and timeline. This creates a pipeline that looks full on paper but converts at sub-10% rates, which kills the Series A growth narrative.

The buying dynamic at Series A is defined by the fact that the company's largest customers are still early adopters who bought the founder's vision, not a repeatable sales process. The typical deal size is $15k-$50k ACV with 6-12 month sales cycles, and the buying committee includes a mid-level manager (champion), a VP-level budget holder, and sometimes a procurement gatekeeper who demands competitive bids. Budget approval is ad hoc - the champion uses discretionary department funds or a specific project budget, and the decision is made within 2-4 weeks if the champion has authority, or 8-12 weeks if it requires VP sign-off. Deals stall at the evaluation stage when marketing has generated interest from non-budget-holders (e.g., individual contributors who downloaded a whitepaper) while sales is pursuing VP-level conversations that marketing has not supported with case studies or ROI calculators. The misalignment means marketing's pipeline contribution is invisible to sales, and sales blames marketing for "bad leads" while marketing blames sales for "poor follow-up."

Sales-Cycle Implications of the Misalignment

The sales cycle at a Series A company with misaligned sales and marketing is a broken funnel that forces sales reps to become de facto marketers. Reps spend 40-50% of their time sourcing their own leads through LinkedIn outreach and cold calls because marketing's leads are unqualified. This creates a "double-dipping" problem where marketing reports 200 leads per month, but sales only works 30 of them because the rest are from non-decision-makers. The ramp time for new sales hires extends from a normal 3-4 months to 6-9 months because they cannot rely on marketing to fill their pipeline. Forecast behavior becomes erratic - sales leadership predicts 120% of quota based on their own pipe, but marketing's pipeline contribution is excluded from the forecast because it never closes. The result is that the CEO sees a combined pipeline of $2M but only closes $200k per quarter, creating a credibility problem with the board.

Pipeline shape is distorted by the misalignment. Marketing generates a high volume of early-stage leads (top-of-funnel) but zero middle-of-funnel assets like case studies, competitive battle cards, or ROI calculators that sales needs to advance deals. Sales, in turn, generates mid-funnel opportunities from their own outreach but cannot scale because they lack marketing's reach. The leaks are concentrated at two points: (1) the transition from marketing qualified to sales accepted, where marketing's leads are rejected by sales 70-80% of the time, and (2) the transition from opportunity to closed-won, where sales has no enablement content to overcome objections. The net effect is that the company's actual sales capacity is 30-50% of what the headcount suggests, because every rep is doing two jobs.

What a Fractional/Interim CRO Looks Like Here

A fractional CRO at a Series A company with sales-marketing misalignment is not a part-time executive who "advises" from a board seat - they are a hands-on operator who spends 3-4 days per week in the office for the first 8 weeks. Their first 90 days are structured around three phases: diagnosis (days 1-30), alignment (days 31-60), and execution (days 61-90). In the diagnosis phase, they interview every sales rep and marketer individually to understand the "language gap" - for example, marketing defines a lead as someone who attended a webinar, while sales defines a lead as someone who has a budget meeting scheduled. They also audit the CRM to find the 10-15 deals that closed in the last quarter and trace them back to their source - this usually reveals that 80% of closed revenue came from founder-led sales or inbound referrals, not from marketing campaigns.

In the alignment phase, the fractional CRO implements a shared definition of "qualified opportunity" that both teams agree on, typically based on BANT (Budget, Authority, Need, Timeline) or a simpler framework like "has a budget conversation scheduled within 30 days." They create a weekly "pipeline review" that forces sales and marketing to sit together and review every deal over $20k, with marketing owning the top-of-funnel metrics and sales owning the close rates. They also establish a 30-day "service level agreement" where marketing commits to delivering X qualified opportunities per week, and sales commits to providing feedback on why each opportunity was accepted or rejected. This is not theoretical - it is enforced with a shared dashboard that the CEO reviews every Monday.

The fractional CRO owns the GTM strategy and the revenue operations function, but they do not own the people management of the sales and marketing heads unless those heads are underperforming. They advise the CEO on whether the current head of sales or head of marketing can scale, which is the key signal for converting to full-time. If the fractional CRO determines that the misalignment is caused by a head of sales who cannot forecast or a head of marketing who cannot generate pipeline, they recommend a full-time CRO hire who can replace one or both. If the misalignment is caused by lack of process (e.g., no CRM discipline, no lead scoring), the fractional CRO can fix it in 90 days and transition to a monthly advisory role.

The Signals to Convert to Full-Time CRO

The decision to convert a fractional CRO to full-time at a Series A company hinges on three signals: pipeline predictability, team capability, and CEO bandwidth. Pipeline predictability is the most important - if after 90 days the fractional CRO has established a 30-day forecast accuracy of +/-15% (meaning the company can predict revenue within 15% variance), then the GTM motion is repeatable and a full-time CRO can scale it. If forecast accuracy remains above +/-30%, the misalignment is structural and requires a permanent leader to overhaul the team.

Team capability is the second signal. If the fractional CRO discovers that the head of sales or head of marketing is the root cause of the misalignment (e.g., the head of sales refuses to use marketing leads, or the head of marketing refuses to align with sales' qualification criteria), then a full-time CRO is needed to replace that person. This is a hard decision for a Series A CEO who may have hired these people as early employees, but the fractional CRO's objectivity can surface the issue. If the team is capable but lacked process, the fractional CRO can train them and step back.

CEO bandwidth is the third signal. At Series A, the CEO typically owns the GTM function and spends 60-70% of their time on sales. If the fractional CRO's engagement reveals that the CEO cannot delegate pipeline management because they are the only one who can close enterprise deals, then a full-time CRO is necessary to free the CEO to focus on product and fundraising. If the CEO can step back after the fractional CRO establishes the process, a part-time advisory role suffices.

The Operating Cadence of the Engagement

The operating cadence for a fractional CRO at a Series A company with sales-marketing misalignment is intense and structured. The first 30 days require 3-4 in-person days per week, with daily standups that include both sales and marketing heads. The fractional CRO personally reviews every deal in the pipeline over $10k and tags each one with its source (marketing-generated, sales-generated, founder-generated). They also shadow two sales calls per week to assess whether sales reps are using marketing collateral or ignoring it. The output of the first 30 days is a "misalignment diagnosis document" that quantifies the revenue lost due to the disconnection - for example, "marketing generated 50 leads that matched sales' ICP but were never contacted because the lead routing was broken."

Days 31-60 shift to a weekly cadence with two in-person days per week. The fractional CRO runs the pipeline review every Monday, where sales and marketing jointly review the top 20 deals and agree on next steps. They also implement a lead scoring model that assigns points based on behavior (e.g., attended a demo) and demographic fit (e.g., title, company size). The output of this phase is a 60-day pipeline forecast that the CEO can take to the board, along with a plan to hire a revenue operations manager if the company is above $3M ARR.

Days 61-90 are transition-oriented. The fractional CRO reduces to one in-person day per week and focuses on documentation - creating a "GTM playbook" that codifies the lead handoff process, the forecast methodology, and the meeting cadences. They also conduct a "readiness assessment" that recommends whether to hire a full-time CRO, promote the head of sales to CRO, or keep the fractional model. The final deliverable is a 12-month GTM plan that includes headcount, budget, and pipeline targets.

The Specific Risks of Not Using an Advisory

The risk of skipping a CRO advisory at a Series A company with sales-marketing misalignment is that a full-time CRO hire can accelerate the dysfunction rather than fix it. A full-time CRO who inherits a misaligned team will spend their first 90 days trying to understand the problem, but they are under pressure to produce revenue immediately. This leads to a common mistake: the new CRO fires the head of sales or head of marketing within 60 days, which creates a leadership vacuum and kills morale. The advisory model allows the company to test whether the misalignment is fixable without making a permanent hire that may not survive.

Another risk is that the CEO, in desperation, hires a CRO from a later-stage company (e.g., a VP of Sales from a $50M ARR company) who implements enterprise processes that are too heavy for Series A. For example, they might install a complex CRM workflow, a six-stage sales process, and a marketing automation system that the 20-person company cannot maintain. The fractional CRO, by contrast, is experienced in Series A constraints and will only implement what the team can sustain.

Finally, the advisory model protects the company's cap table. A full-time CRO at Series A typically demands 2-5% equity, which is a significant dilution for a role that may not work out. A fractional CRO charges a monthly fee ($15k-$25k per month for 3-4 days per week) with no equity, giving the company the flexibility to pivot if the misalignment cannot be resolved.

FAQ

A question: How do I know if the sales-marketing misalignment is caused by the people or the process? The signal is whether the same misalignment existed before the current heads of sales and marketing were hired. If the company has had multiple heads of sales or marketing and the misalignment persists, it is a process problem. If the misalignment started when the current heads were hired, it is a people problem. The fractional CRO will trace the root cause by interviewing the team and reviewing the CRM history - if every sales rep complains about the same marketing lead quality issue across three different marketing leaders, the process is broken.

A question: Can a fractional CRO fix the misalignment if the CEO is the bottleneck? Yes, but only if the CEO is willing to delegate. The fractional CRO's first task is to assess whether the CEO is the de facto sales leader who closes 70%+ of deals. If so, the fractional CRO must work with the CEO to document their sales process and then hire a sales rep to replicate it. If the CEO refuses to delegate, the fractional CRO should advise the board that a full-time CRO is needed to force the delegation, or the company will not scale.

A question: What is the minimum ARR for a fractional CRO to make sense at Series A? The minimum is $1M ARR, but the company must have at least two full-time sales reps and one full-time marketer. Below $1M ARR, the founder can fix the misalignment themselves by being the bridge between sales and marketing. Above $1M ARR, the misalignment costs the company $200k-$500k in lost revenue per year, which justifies the $15k-$25k per month advisory fee.

A question: How do I measure the success of a fractional CRO engagement? The primary metric is the ratio of marketing-generated pipeline to sales-generated pipeline. Before the engagement, this ratio is typically 20% marketing / 80% sales. After 90 days, it should shift to 40% marketing / 60% sales, with the marketing-generated pipeline closing at the same rate as sales-generated pipeline. The secondary metric is forecast accuracy - it should improve from +/-50% to +/-20% within 90 days. If neither metric moves, the engagement has failed and a full-time CRO hire is the only option.

Sources